ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs Opportunities

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best small-cap value stocks to buy. On April 20, ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) confirmed the Food and Drug Administration’s approval of Pimozide Tablets in 1 mg and 2 mg strengths.

ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs Opportunities

Following approval, the company has launched Pimozide tablets, a generic version of the reference listed drug (RLD) Orap. The company has also successfully secured 180-day CGT exclusivity for the drug.

The launch underscores Ani Pharmaceuticals’ focus on bringing to market products with limited competition while offering generic alternatives to customers. Pimozide annual sales in the US total about $3.1 million

The launch of Pimozide tablets comes against the backdrop of the company’s launch of Carbamazepine Extended-Release Capsules in 100 mg, 200 mg, and 300 mg strengths. The launch of the generic version of RLD Carbatrol continues to strengthen the company’s generic portfolio. U.S. annual sales for Carbamazepine Extended-Release Capsules total approximately $65 million.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is a diversified biopharmaceutical company that develops, manufactures, and commercializes high-quality branded, generic, and over-the-counter pharmaceuticals. They focus on rare diseases (ophthalmology, oncology) and maintain U.S.-based manufacturing facilities, including specialized capabilities for potent, high-containment products.

While we acknowledge the risk and potential of ANIP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ANIP and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Most Oversold Canadian Stocks to Invest In and 10 Best Stocks to Buy in 2026 According to Billionaire George Soros.

Disclosure: None. Follow Insider Monkey on Google News.